Rapid infectious disease test Xpert®

for genesMRSAclinical

Control of MRSA in healthcare settings requires rapid and accurate tests to detect colonized patients. Approximately 171,200 healthcare-associated MRSA infections are acquired annually in the European Union (EU), resulting in 5,400 attributable deaths, more than 1 million excess days of hospitalization and € 380 million in excess in-hospital costs1 Between 2 and 53 million people are estimated to carry MRSA worldwide2 The average length of stay (LOS) for all MRSA patients in the EU is 11.5 days with an average attributable cost of €7,478 per patient3 The Solution Xpert® MRSA NxG is an accurate, fast, on-demand PCR test that will help to: Optimize the effectiveness of your infection control program and guide the judicious use of barrier precautions Guide decolonization practices that reduce infection rates and decrease MRSA transmission Help decrease LOS and improve patient and bed management Help reduce infection control costs by limiting unnecessary use of isolation rooms and improve clinical outcomes Detect the presence of MRSA by targeting both the orfX SCCmec junction and the mecA or mecC genes for a more accurate MRSA detection Improve antibiotic stewardship by avoiding unnecessary The Impact Xpert MRSA NxG is an accurate, fast, on-demand PCR test that provides actionable results in about an hour. Shift your lab from reactive to proactive Rapidly identify MRSA colonized patients that require contact precautions to reduce the risk of transmission and avoid costly outbreaks